Module 5: Regulatory strategy and commercialisation
As your company gears up towards expansion and commercialisation into international markets, this module will provide guidance on key considerations when entering specific key markets for life science, including regulatory and reimbursement perspectives.
It will also provide insights on enabling a flexible market access strategy, and what to keep in mind when faced with various decision pathways.
Date: 27 January 2026
Expert/s: GBA Key2Compliance, Scaling Life Sciences (Martin Stenfelt)
Key Takeaways
- Regulatory aspects for executives, strategies for market access.
- Primary considerations and low hanging fruits for entering a major market.
- Opportunities and challenges for specific markets.
- How to leverage current assets/position of your company and build commercial partnerships.
- Finding a successful route to market based on experience and key learnings from the industry.